Vertex Pharmaceuticals VRTX Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vertex Pharmaceuticals's interest paid?
- Vertex Pharmaceuticals (VRTX) reported interest paid of $3.2M in Q1 2026.
- How has Vertex Pharmaceuticals's interest paid changed year-over-year?
- Vertex Pharmaceuticals's interest paid increased by 18.5% year-over-year, from $2.7M to $3.2M.
- What is the long-term trend for Vertex Pharmaceuticals's interest paid?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's interest paid has grown at a -31.5% compound annual growth rate (CAGR), from $56.3M to $12.4M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.